Wei‐xian Chen

2.3k total citations
48 papers, 1.9k citations indexed

About

Wei‐xian Chen is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Wei‐xian Chen has authored 48 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 31 papers in Cancer Research and 9 papers in Oncology. Recurrent topics in Wei‐xian Chen's work include MicroRNA in disease regulation (23 papers), Circular RNAs in diseases (15 papers) and Cancer-related molecular mechanisms research (13 papers). Wei‐xian Chen is often cited by papers focused on MicroRNA in disease regulation (23 papers), Circular RNAs in diseases (15 papers) and Cancer-related molecular mechanisms research (13 papers). Wei‐xian Chen collaborates with scholars based in China and Switzerland. Wei‐xian Chen's co-authors include Jinhai Tang, Shanliang Zhong, Jianhua Zhao, Mengmeng Lv, Qing Hu, Tengfei Ma, Lin Chen, Dandan Yu, Luo Zhou and Minghua Ji and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Wei‐xian Chen

46 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei‐xian Chen China 22 1.7k 1.4k 224 153 120 48 1.9k
Zhendong Shi China 24 1.7k 1.0× 1.3k 0.9× 163 0.7× 93 0.6× 84 0.7× 37 2.0k
Xiaoqu Hu China 14 1.6k 1.0× 1.3k 1.0× 632 2.8× 102 0.7× 98 0.8× 35 2.3k
Shan Rao China 11 872 0.5× 668 0.5× 291 1.3× 311 2.0× 197 1.6× 19 1.4k
Matteo Ligorio United States 4 1.0k 0.6× 1.0k 0.7× 502 2.2× 122 0.8× 125 1.0× 6 1.6k
Haiou Yang China 18 2.0k 1.2× 1.6k 1.2× 274 1.2× 201 1.3× 516 4.3× 32 2.4k
Samuel K. McBrayer United States 18 778 0.5× 484 0.3× 196 0.9× 116 0.8× 103 0.9× 44 1.2k
Nathaniel R. Campbell United States 20 1.2k 0.7× 631 0.5× 510 2.3× 180 1.2× 129 1.1× 24 1.7k
Dingzhi Huang China 21 1.4k 0.8× 1.2k 0.9× 499 2.2× 162 1.1× 364 3.0× 76 2.0k
Zhenlin Hou China 11 899 0.5× 492 0.4× 204 0.9× 274 1.8× 123 1.0× 22 1.2k
Riccardo Sgarra Italy 24 1.5k 0.9× 754 0.5× 280 1.3× 144 0.9× 129 1.1× 62 1.9k

Countries citing papers authored by Wei‐xian Chen

Since Specialization
Citations

This map shows the geographic impact of Wei‐xian Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐xian Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐xian Chen more than expected).

Fields of papers citing papers by Wei‐xian Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei‐xian Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐xian Chen. The network helps show where Wei‐xian Chen may publish in the future.

Co-authorship network of co-authors of Wei‐xian Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Wei‐xian Chen. A scholar is included among the top collaborators of Wei‐xian Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei‐xian Chen. Wei‐xian Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Su‐Jin, et al.. (2024). Exosome-delivered microRNAs confer adriamycin-resistance through modulating the immune and metabolism-related gene PTEN in HER2-negative breast cancer.. Journal of Clinical Oncology. 42(16_suppl). e12500–e12500. 1 indexed citations
2.
Wu, Jiahao, et al.. (2023). Identification of a novel five ferroptosis-related gene signature as a promising prognostic model for breast cancer. Journal of Cancer Research and Clinical Oncology. 149(18). 16779–16795. 4 indexed citations
3.
Wu, Jiahao, et al.. (2023). Identification of cuproptosis-related gene SLC31A1 and upstream LncRNA-miRNA regulatory axis in breast cancer. Scientific Reports. 13(1). 18390–18390. 17 indexed citations
4.
Zhu, Bei, et al.. (2020). Identification of prognostic significance of BIRC5 in breast cancer using integrative bioinformatics analysis. Bioscience Reports. 40(2). 37 indexed citations
5.
Zhu, Bei, Wei‐xian Chen, Yue Fu, et al.. (2020). <p>MicroRNA-27a-3p Reverses Adriamycin Resistance by Targeting BTG2 and Activating PI3K/Akt Pathway in Breast Cancer Cells</p>. OncoTargets and Therapy. Volume 13. 6873–6884. 12 indexed citations
6.
Chen, Wei‐xian, Lingyun Xu, Lin Cheng, et al.. (2019). <p>Bioinformatics analysis of dysregulated microRNAs in exosomes from docetaxel-resistant and parental human breast cancer cells</p>. Cancer Management and Research. Volume 11. 5425–5435. 15 indexed citations
7.
Chen, Wei‐xian, Lingyun Xu, Qi Qian, et al.. (2018). d Rhamnose β-hederin reverses chemoresistance of breast cancer cells by regulating exosome-mediated resistance transmission. Bioscience Reports. 38(5). 19 indexed citations
8.
Tian, Ye, et al.. (2018). Down-regulation of long non-coding RNA AFAP1-AS1 inhibits tumor growth, promotes apoptosis and decreases metastasis in thyroid cancer. Biomedicine & Pharmacotherapy. 99. 191–197. 27 indexed citations
9.
Liu, Xinfeng, et al.. (2015). TGF-β1 prevents blood–brain barrier damage and hemorrhagic transformation after thrombolysis in rats. Experimental Neurology. 266. 120–126. 33 indexed citations
10.
Yu, Dandan, Mengmeng Lv, Wei‐xian Chen, et al.. (2015). Role of miR-155 in drug resistance of breast cancer. Tumor Biology. 36(3). 1395–1401. 58 indexed citations
11.
Mao, Ling, Jian Li, Wei‐xian Chen, et al.. (2015). Exosomes decrease sensitivity of breast cancer cells to adriamycin by delivering microRNAs. Tumor Biology. 37(4). 5247–5256. 80 indexed citations
12.
Hu, Qing, Jianping Gong, Jian Li, et al.. (2014). Down-regulation of miRNA-452 is Associated with Adriamycin-resistance in Breast Cancer Cells. Asian Pacific Journal of Cancer Prevention. 15(13). 5137–5142. 47 indexed citations
13.
Chen, Wei‐xian, Mengmeng Lv, Lin Chen, et al.. (2014). Exosomes from docetaxel-resistant breast cancer cells alter chemosensitivity by delivering microRNAs. Tumor Biology. 35(10). 9649–9659. 127 indexed citations
14.
Cao, Yuezhou, et al.. (2014). Plasminogen activator inhibitor-1 4G/5G polymorphism and ischemic stroke risk: a meta-analysis in Chinese population. International Journal of Neuroscience. 124(12). 874–881. 12 indexed citations
15.
Chen, Wei‐xian, Qing Hu, Mantang Qiu, et al.. (2013). miR-221/222: promising biomarkers for breast cancer. Tumor Biology. 34(3). 1361–1370. 100 indexed citations
16.
Hu, Qing, Wei‐xian Chen, Shanliang Zhong, et al.. (2013). Current Progress in the Treatment of Metaplastic Breast Carcinoma. Asian Pacific Journal of Cancer Prevention. 14(11). 6221–6225. 25 indexed citations
17.
Chen, Wei‐xian, Shanliang Zhong, Minghua Ji, et al.. (2013). MicroRNAs delivered by extracellular vesicles: an emerging resistance mechanism for breast cancer. Tumor Biology. 35(4). 2883–2892. 51 indexed citations
18.
Ding, Haixia, et al.. (2012). Lack of association of polymorphism in miRNA-196a2 with Parkinson's disease risk in a Chinese population. Neuroscience Letters. 514(2). 194–197. 6 indexed citations
19.
Qian, Yun, Wei‐xian Chen, Jianqing Wu, et al.. (2010). Association of polymorphism of DNA repair gene XRCC1 with sporadic late-onset Alzheimer's disease and age of onset in elderly Han Chinese. Journal of the Neurological Sciences. 295(1-2). 62–65. 21 indexed citations
20.
Chen, Wei‐xian, et al.. (2004). New progress in bacterium biofilm. The Journal of Microbiology. 24(1). 46–48. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhendong Shi Breakdown of academic impact, for papers by Xiaoqu Hu Breakdown of academic impact, for papers by Shan Rao Breakdown of academic impact, for papers by Matteo Ligorio Breakdown of academic impact, for papers by Haiou Yang Breakdown of academic impact, for papers by Samuel K. McBrayer Breakdown of academic impact, for papers by Nathaniel R. Campbell Breakdown of academic impact, for papers by Dingzhi Huang Breakdown of academic impact, for papers by Zhenlin Hou Breakdown of academic impact, for papers by Riccardo Sgarra
Rankless by CCL
2026